Dengue Fever Program

About Sixty Degrees Pharmaceuticals

Sixty Degrees Pharmaceuticals is a U.S.-based biotech targeting major global infectious diseases like malaria, dengue, and COVID-19. The company appears to be advancing a portfolio of small-molecule therapeutics, with a recent commercial launch indicated for malaria prevention. Its strategy involves both product development and commercialization to serve travelers and endemic regions, positioning itself at a critical intersection of public health need and market opportunity.

Therapeutic Areas